Tesamorelin storage and reconstitution: the practical handling protocol
Tesamorelin is supplied as a lyophilised (freeze-dried) powder that must be reconstituted with a sterile diluent before use. The handling protocol is the unglamorous half of any Tesamorelin research project — temperature excursions during shipping, reconstitution errors, and storage mistakes degrade the 44-residue peptide faster than the on-label specification implies. The protocol below is the standard the published clinical-trial work assumes researchers already know.
Storage of the lyophilised vial
The unreconstituted lyophilised Tesamorelin vial is stable at refrigerated temperature (2-8°C) for at least 24 months from manufacture when sealed. Long-term storage at -20°C is also acceptable for extended-period research-supply contexts. The vial should be protected from light at all times — the trans-3-hexenoyl modification at the N-terminus is somewhat photosensitive, and accumulated light exposure degrades the peptide faster than the temperature spec implies.
Shipping considerations: Tesamorelin tolerates short-duration ambient-temperature exposure during transit (cold-chain delivery is the standard, but a 24-48 hour ambient excursion does not destroy the molecule). Repeated freeze-thaw cycles are more damaging than a single short ambient exposure. The lyophilised format itself is more stable than reconstituted Tesamorelin; the time-sensitive handling window starts at reconstitution.
Bacteriostatic water vs sterile water
The standard Tesamorelin reconstitution diluent in research protocols is bacteriostatic water (water for injection with 0.9% benzyl alcohol as preservative). The bacteriostatic preservative substantially extends the post-reconstitution refrigerated stability — typically 21-28 days vs ~24 hours for sterile water without preservative. For any research protocol where the reconstituted vial will be re-entered more than once, bacteriostatic water is the correct choice.
Sterile water (no preservative) is acceptable for single-use protocols where the entire vial is administered immediately. The peptide chemistry does not differ between the two diluents; the difference is in microbial-growth resistance of the reconstituted solution over time.
Acidic-buffer diluents (e.g., 0.6% acetic acid water) are used for some peptides that have solubility issues at neutral pH. Tesamorelin reconstitutes cleanly in standard bacteriostatic water and does not require an acidic buffer.
The reconstitution protocol, step by step
The standard reconstitution protocol for a 10 mg Tesamorelin vial:
- Equilibrate the vial. Remove the lyophilised Tesamorelin vial from refrigeration and let it reach room temperature on the bench for 10-15 minutes. Cold-vial reconstitution produces local clumping; equilibrated vials accept the diluent more uniformly.
- Wipe the septums. Wipe the rubber septum of both the Tesamorelin vial and the bacteriostatic water vial with a 70% isopropyl alcohol swab. Let dry for 30 seconds.
- Draw the diluent. Using a 1 mL or 3 mL transfer syringe with a 21G needle, draw 1 mL of bacteriostatic water. The choice of 1 mL produces a 10 mg/mL concentration; researchers requiring a different concentration can use 2 mL (5 mg/mL) or 0.5 mL (20 mg/mL) — the free reconstitution calculator handles the dose-volume math.
- Inject slowly down the vial wall. Inject the bacteriostatic water slowly along the inside wall of the Tesamorelin vial. Never inject the stream directly onto the lyophilised powder — direct impact damages peptide structure and produces dissolution-resistant pellets.
- Swirl gently — never shake. Gently swirl the vial in a circular motion for 30-60 seconds until the powder fully dissolves. Tesamorelin in solution is clear and colourless. Visible particles or persistent cloudiness after 2-3 minutes of swirling indicates a reconstitution failure (likely too-rapid injection or contamination). Vigorous shaking creates foam and disrupts the peptide secondary structure.
- Label and refrigerate. Label the reconstituted vial with the reconstitution date. Refrigerate at 2-8°C. The standard refrigerated re-entry window with bacteriostatic water is 21-28 days; tighter protocols use 14 days.
Concentration and U-100 syringe math
The research-standard 2 mg daily dose drawn from a 10 mg vial reconstituted to common concentrations:
- 10 mg / 1 mL bacteriostatic water = 10 mg/mL. The 2 mg dose is 0.2 mL drawn on a U-100 insulin syringe. Reading the U-100 calibration (100 units = 1 mL), 0.2 mL is 20 units. The 30u or 50u insulin-syringe sizes are appropriate; the 100u size is over-sized for this draw.
- 10 mg / 2 mL bacteriostatic water = 5 mg/mL. The 2 mg dose is 0.4 mL = 40 units on a U-100 insulin syringe. The 50u or 100u syringe sizes are appropriate.
- 10 mg / 0.5 mL bacteriostatic water = 20 mg/mL. The 2 mg dose is 0.1 mL = 10 units on a U-100 insulin syringe. The 30u syringe gives the finest precision.
The free reconstitution calculator handles non-standard vial sizes (5 mg, 15 mg, 20 mg) and non-standard reconstitution volumes automatically. The HowTo schema on that page covers the seven-step reconstitution protocol with structured-data markup so the calculator can be discovered through Google’s “how to reconstitute X” search surface.
Reconstituted-solution storage
Once Tesamorelin is reconstituted with bacteriostatic water:
- Refrigerate at 2-8°C immediately after reconstitution.
- Protect from light. Tesamorelin’s lipid modification is photosensitive; brown-glass or foil-wrapped storage prolongs the effective shelf-life.
- Re-entry window: 21-28 days with bacteriostatic water; 14 days for tighter research protocols. Do not extend beyond the window — both microbial-contamination risk and peptide-degradation risk rise.
- Allow the vial to equilibrate to room temperature for ~5 minutes before drawing a dose. Cold-vial draw is uncomfortable for the researcher (sting on injection) and can cause minor injection-site irritation.
- Never freeze reconstituted Tesamorelin. The freeze-thaw cycle destroys the peptide.
UAE research-supply note
Wellness Labs supplies Tesamorelin as lyophilised research-grade powder in 10 mg vials. Each batch ships with HPLC purity verification (≥98%), mass-spectrometry confirmation of the parent ion (~5,136 Da), and a certificate of analysis with batch traceability. Shipping is cold-chain across the UAE; same-day Dubai delivery, next-business-day across the rest of the UAE. The Tesamorelin parent overview covers the analytical-verification framework in depth.
Further reading
- Tesamorelin parent overview.
- Tesamorelin dosing in research protocols.
- Tesamorelin side effects and tolerability.
- Bacteriostatic water — research-supply guide.
- Free reconstitution calculator (HowTo-schema-indexed).
- General peptide reconstitution and CoA guide.
Last reviewed 2 June 2026. Editorial inbox: info@uaewellnesslab.com.
Frequently asked questions
- What diluent should Tesamorelin be reconstituted with?
- Bacteriostatic water (water for injection with 0.9% benzyl alcohol preservative) is the standard Tesamorelin reconstitution diluent. The bacteriostatic preservative extends the refrigerated post-reconstitution shelf-life to 21-28 days; sterile water without preservative produces a roughly 24-hour shelf-life. For any multi-use research protocol, bacteriostatic water is the correct choice.
- How much bacteriostatic water for a 10 mg Tesamorelin vial?
- The standard reconstitution volume for a 10 mg Tesamorelin vial is 1 mL, producing a 10 mg/mL concentration. From this, the 2 mg research dose is 0.2 mL (20 units on a U-100 insulin syringe). Alternative reconstitution volumes are acceptable — 2 mL produces 5 mg/mL (2 mg dose = 0.4 mL = 40 units); 0.5 mL produces 20 mg/mL (2 mg dose = 0.1 mL = 10 units). The choice depends on the syringe size researchers prefer for the dose volume.
- How long does reconstituted Tesamorelin last?
- Refrigerated at 2-8°C with bacteriostatic water, the standard re-entry window is 21-28 days. Tighter research protocols use 14 days. The molecule's lipid modification is photosensitive — protect from light during refrigerated storage. Never freeze reconstituted Tesamorelin; freeze-thaw cycles destroy the peptide.
- What is the correct technique for adding bacteriostatic water to a Tesamorelin vial?
- Wipe both vial septums with 70% isopropyl alcohol. Draw the bacteriostatic water with a 21G transfer needle. Inject the water slowly along the inside wall of the Tesamorelin vial — never directly onto the lyophilised powder, which damages the peptide structure. Swirl the vial gently in a circular motion for 30-60 seconds until the powder fully dissolves. Never shake the vial — shaking creates foam and disrupts peptide structure.
- How should a Tesamorelin vial be stored before reconstitution?
- Store the lyophilised vial at refrigerated temperature (2-8°C) protected from light. Long-term storage at -20°C is also acceptable. The unreconstituted vial is stable for at least 24 months from manufacture when sealed and stored correctly. Repeated freeze-thaw cycles are more damaging than a short ambient excursion.
- How is the dose drawn on a U-100 insulin syringe?
- U-100 insulin syringes are calibrated as 100 units per 1 mL. The 30-unit, 50-unit, and 100-unit sizes share this calibration; they differ only in maximum draw volume. For a 10 mg/mL Tesamorelin reconstitution, the 2 mg dose is 0.2 mL = 20 units. The 30-unit insulin syringe provides the finest precision for this small-volume draw. The free reconstitution calculator at /tools/reconstitution-calculator handles the dose-volume math for non-standard reconstitution concentrations.